Oyster Point Pharma, Inc. (OYST) Financial Statements
Oyster Point Pharma, Inc. (OYST) files with the U.S. Securities and Exchange Commission under CIK 0001720725. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2021
- Revenue
- $24.54 million
- Net Income
- -$100.66 million
- Total Assets
- $222.62 million
- Net Cash from Operations
- -$89.37 million
Fiscal year ended Dec 31, 2021. Latest periodic SEC filing: Nov 10, 2022. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for OYST in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History